ARCHIVES

Sorafenib Targets AML Driven By Mutant FLT3 Gene

This article is from The Cancer Letter archive.

Vol. 31 No. 2 | February 29, 2008

Download PDF Visit The Full Archive

Related Articles

In Brief: Ingell Vows To Broaden Indirect Cost Inquiry; Gallo, Fauci Make ‘Most Prolific Scientist’ List

February 7, 1992

New NCI Director Proposes $9 Million Community Cancer Centers Program.

September 8, 2006

Zytiga and Prednisone Extends Overall Survival in mCRPC Trial

October 31, 2014

Additional DCE Contract Concepts

November 16, 1984

Breast Cancer: Working Group Sets Broad Agenda For Genetic Research

January 10, 1997

UC Breast Cancer ProgramTo Award $20 Million In Grants

December 16, 1994